The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The IDC has a potential value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods.
Under this IDC, Xlcare Pharmaceuticals will supply levetiracetam tablets to the VA, Department of Defense, Indian Health Service, and Bureau of Prisons, with distribution through the VA and DoD's Pharmaceutical Prime Vendor Programs. The contract was competitively awarded with no set-aside, and the solicitation was issued in commercial item format under FAR Part 12. The procured pharmaceutical items support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program and distribution to VA medical centers.
Generated 4/3/24, 10:10 AM